13 African countries launch clinical trials to enhance treatment of mild COVID-19 cases

By Bai LinUnreguser
  • World
  • Wednesday, 25 Nov 2020

NAIROBI, Nov. 24 (Xinhua) -- Thirteen African countries on Tuesday announced a collaborative venture with international research networks to implement clinical trials aimed at enhancing treatment of mild COVID-19 cases.

The Drugs for Neglected Diseases Initiative (DNDi), an international drugs research entity, said in a statement released in Nairobi that the clinical trials will be conducted in 19 sites to help identify therapeutics that could prevent COVID-19 patients from reaching critical stages.

Subscribe now for a chance to win your dream holiday!

Monthly Plan


Annual Plan


Billed as RM148.00/year

1 month

Free Trial

For new subscribers only

Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Next In World

US antitrust agency probes ‘surveillance pricing’
Germany bans Muslim association for pursuing radical Islam
Ireland data centres consume more power than houses
Survivors recount trauma as New Zealand releases child abuse report
'Dark and sorrowful day': New Zealand PM promises reform after inquiry finds 200,000 abused in care
Netflix is nearly doubling its video game catalogue
Mark Zuckerberg aims to rival OpenAI, Google with�new Llama AI model
Blast at Jose Cuervo plant in Mexico's Tequila kills at least five people
Google’s US$23bil plan to buy cybersecurity startup Wiz falls apart
Bangladesh partially restores telecommunication services as protests taper off

Others Also Read